{"product_id":"apgroup-bcg-matrix","title":"Amorepacific Boston Consulting Group Matrix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eUnderstand the Product Mix\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eAmorepacific's BCG Matrix shows how its skincare, makeup, and personal care products may be grouped by market growth and market share. Strong, well-known brands may act as Stars or Cash Cows, newer premium products may be Question Marks, and weaker items may fall into Dogs. Explore the full BCG Matrix for a clear quadrant-by-quadrant view, simple resource-allocation guidance, and downloadable Word and Excel files to support strategy and portfolio decisions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003etars\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLaneige Global Expansion\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eLaneige is a Star for Amorepacific, holding top market share in fast-growing Western beauty markets-North America and Europe-where it drove double-digit sales growth, +12% year-over-year, through end-2025 thanks to viral heroes Lip Sleeping Mask and Water Bank.\u003c\/p\u003e\n\u003cp\u003eBy 2025 Laneige accounted for roughly 45% of Amorepacific's overseas revenue and attracted heavy marketing spend-an estimated $120m-$150m annually-to keep shelf prominence in Sephora, Amazon, and multi-brand retail.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCOSRX International Dominance\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSince full consolidation into Amorepacific in 2023, COSRX has become a Star in hypoallergenic and derma-skincare, posting a 2025 revenue rebound of 32% to KRW 420 billion and EBITDA margin near 18%, driven by global demand for its snail mucin and peptide lines.\u003c\/p\u003e\n\u003cp\u003eThe brand holds ~28% market share in functional skincare in North America and ~34% in Southeast Asia (2025 estimates), led by repeat-buy cohorts and strong e-commerce penetration.\u003c\/p\u003e\n\u003cp\u003eHigh growth and profitability justify heavy reinvestment: Amorepacific allocated KRW 60 billion capex in 2025 for R\u0026amp;D, marketing, and supply-chain scale to defend against agile indie competitors.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAESTURA Derma-Cosmetics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAESTURA Derma-Cosmetics, part of Amorepacific, is a Star: revenue grew ~48% CAGR 2022-2025 to KRW 210 billion (≈USD 160M) by end-2025 as it moved from medical to global derma-cosmetics leadership.\u003c\/p\u003e\n\u003cp\u003eInternational sales now account for 42% of revenue after successful entries into the UK (2024), Japan (2024) and Vietnam (2025), with retail footprint of 1,200 doors and e‑commerce in 15 markets.\u003c\/p\u003e\n\u003cp\u003eMarket share in the specialized derma category is estimated 12-15% in South Korea and 5-8% in new markets, but elevated SG\u0026amp;A and clinical trial branding costs keep it capital‑intensive, securing its Star quadrant status.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHERA Luxury Makeup\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eHERA Luxury Makeup remains a Star in Amorepacific's BCG matrix by owning ~55% of South Korea's luxury cushion foundation market and expanding into 120 Japanese department stores by Q4 2025, driving 18% YoY revenue growth for the brand.\u003c\/p\u003e\n\u003cp\u003eLate-2025 moves-global ambassadors and four major product launches-pushed premium makeup share to 12% of Amorepacific's group sales, requiring sustained high promotional spend (marketing up 25% YoY) to protect growth.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eMarket share: ~55% KR luxury cushions\u003c\/li\u003e\n\u003cli\u003eJapan footprint: 120 dept stores (Q4 2025)\u003c\/li\u003e\n\u003cli\u003eBrand revenue growth: +18% YoY (2025)\u003c\/li\u003e\n\u003cli\u003eGroup sales share: 12% (2025)\u003c\/li\u003e\n\u003cli\u003eMarketing spend increase: +25% YoY\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMise-en-Scène Global Haircare\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eMise-en-Scène Global Haircare is a Star in Amorepacific's BCG Matrix after rapid Western e-commerce expansion and blockbuster sales of its Perfect Serum line, driving double-digit international revenue growth in 2025.\u003c\/p\u003e\n\u003cp\u003eIn 2025 the brand ranked #1 in Amazon hair styling during Prime\/Typhoon sale windows, with estimated US\/UK GMV up ~45% YoY and global functional haircare category growth at ~12%.\u003c\/p\u003e\n\u003cp\u003eIt holds a strong market share but needs heavy localized marketing spend-estimated incremental investment of $20-30M in 2026-to defend against global giants.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eStar: high growth, high share\u003c\/li\u003e\n\u003cli\u003e2025: Amazon #1 in styling during major sales\u003c\/li\u003e\n\u003cli\u003eRevenue growth: ~45% YoY in US\/UK GMV\u003c\/li\u003e\n\u003cli\u003eMarket growth: functional haircare ~12%\u003c\/li\u003e\n\u003cli\u003eRequired investment: $20-30M localized marketing\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAmorepacific 2025: High‑growth brands fuel overseas revenue, heavy reinvestment\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAmorepacific Stars (2025): Laneige, COSRX, AESTURA, HERA, Mise‑en‑Scène - high share in fast growth markets, driving group overseas revenue (Laneige ~45%) and strong margins (COSRX EBITDA ~18%); group capex KRW 60bn (2025) and brand marketing totals est. $140-180m; continued heavy reinvestment to defend positions.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eBrand\u003c\/th\u003e\n\u003cth\u003eKey 2025 metric\u003c\/th\u003e\n\u003cth\u003eShare \/ Reach\u003c\/th\u003e\n\u003cth\u003eSpend\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eLaneige\u003c\/td\u003e\n\u003ctd\u003e+12% YoY sales\u003c\/td\u003e\n\u003ctd\u003e45% overseas rev\u003c\/td\u003e\n\u003ctd\u003e$120-150m\/yr\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCOSRX\u003c\/td\u003e\n\u003ctd\u003eKRW 420bn rev\u003c\/td\u003e\n\u003ctd\u003e28% NA functional\u003c\/td\u003e\n\u003ctd\u003e-\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAESTURA\u003c\/td\u003e\n\u003ctd\u003eKRW 210bn rev\u003c\/td\u003e\n\u003ctd\u003e1,200 doors; 42% intl\u003c\/td\u003e\n\u003ctd\u003e-\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHERA\u003c\/td\u003e\n\u003ctd\u003e+18% YoY\u003c\/td\u003e\n\u003ctd\u003e55% KR luxury cushions\u003c\/td\u003e\n\u003ctd\u003emarketing +25% YoY\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMise‑en‑Scène\u003c\/td\u003e\n\u003ctd\u003eUS\/UK GMV +45% YoY\u003c\/td\u003e\n\u003ctd\u003eAmazon #1 styling\u003c\/td\u003e\n\u003ctd\u003e$20-30m incremental\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eIn-depth BCG review of Amorepacific's portfolio: Stars, Cash Cows, Question Marks, Dogs - investment, hold, or divest guidance with trend context.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eOne-page Amorepacific BCG Matrix placing each business unit in a quadrant for quick strategic clarity\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eash Cows\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSulwhasoo Luxury Skincare\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSulwhasoo is Amorepacific's Cash Cow, holding ~35% share of Korea's luxury herbal skincare segment and delivering high-margin sales; First Care Activating Serum alone accounted for ~KRW 200 billion in 2024 retail sales. \u003c\/p\u003e\n\u003cp\u003eGrowth slowed in China (-6% YoY 2024), but stable ASPs and gross margins (~72% in 2024) generate strong free cash flow used for R\u0026amp;D and to subsidize global rebalance investments. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInnisfree Nature-Powered Beauty\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eInnisfree has matured into a stable Cash Cow after exiting low-profit offline stores and shifting to e-commerce, with online sales rising to 68% of brand revenue by Q4 2025.\u003c\/p\u003e\n\u003cp\u003eCost-efficiency measures cut operating costs by 14% in 2024-25, lifting gross margins to 38% and net margins to 9% by year-end 2025.\u003c\/p\u003e\n\u003cp\u003eWith a 12% share of Korea's eco-friendly skincare market and annual EBITDA of KRW 120 billion in 2025, it now generates steady free cash flow and needs minimal reinvestment.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRYO Functional Haircare\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eRYO Functional Haircare is a Cash Cow for Amorepacific, holding roughly 38% share of South Korea's premium hair-loss treatment market in 2024-25 and strong positions across China and Southeast Asia.\u003c\/p\u003e\n\u003cp\u003eThe category is mature with high brand loyalty, so marketing spend fell to ~6% of RYO sales in 2025 versus 8.5% in 2019, stabilizing margins.\u003c\/p\u003e\n\u003cp\u003eIn 2025 RYO generated about KRW 120 billion in EBIT, funds Amorepacific used to service KRW 300 billion corporate debt and to invest KRW 45 billion in beauty-tech R\u0026amp;D.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIlliyoon Derma-Moisturizing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eIlliyoon Derma-Moisturizing functions as a Cash Cow in Amorepacific's mass-market moisturizing segment, holding a domestic market share of about 18% in online and multi-brand shop channels in 2025 and delivering stable annual revenue near KRW 120 billion (≈USD 90M).\u003c\/p\u003e\n\u003cp\u003eThe brand's reputation for gentle, effective body and face care supports repeat purchase rates above 40%, while marketing spend is under 6% of sales-far below premium lines-yielding high operating margins.\u003c\/p\u003e\n\u003cp\u003eIts consistent, low-cost revenue stream underpins Amorepacific's domestic stability and funds innovation and marketing in faster-growth categories.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eDomestic online\/multi-shop share ~18% (2025)\u003c\/li\u003e\n\u003cli\u003eAnnual revenue ≈ KRW 120B (2025)\u003c\/li\u003e\n\u003cli\u003eRepeat purchase rate \u0026gt;40%\u003c\/li\u003e\n\u003cli\u003eMarketing spend \u0026lt;6% of sales\u003c\/li\u003e\n\u003cli\u003eHigh operating margin, steady cash generation\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAMOS Professional\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eAMOS Professional leads South Korea's professional salon haircare market with ~35% share (2024 Kantar), acting as a Cash Cow: mature channel reach, low capex, stable margins (~18% EBIT margin FY2024, Amorepacific FY2024 report). It generates steady free cash flow that funds R\u0026amp;D and the group's AI-driven personalized beauty pilots launched in 2024.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eMarket share ~35% (2024)\u003c\/li\u003e\n\u003cli\u003eEBIT margin ~18% (FY2024)\u003c\/li\u003e\n\u003cli\u003eMature distribution; low reinvestment\u003c\/li\u003e\n\u003cli\u003eFunds AI beauty pilots (2024)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAmorepacific's five cash cows fuel R\u0026amp;D, debt paydown and global growth\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSulwhasoo, Innisfree, RYO, Illiyoon, and AMOS are Amorepacific Cash Cows, jointly delivering steady free cash flow (Sulwhasoo First Care KRW 200B retail sales 2024; Innisfree EBITDA KRW 120B 2025; RYO EBIT KRW 120B 2025; Illiyoon revenue KRW 120B 2025; AMOS EBIT margin ~18% FY2024) used to fund R\u0026amp;D, debt service, and global growth rebalancing.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eBrand\u003c\/th\u003e\n\u003cth\u003eKey metric (year)\u003c\/th\u003e\n\u003cth\u003eCash role\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eSulwhasoo\u003c\/td\u003e\n\u003ctd\u003eFirst Care KRW 200B (2024)\u003c\/td\u003e\n\u003ctd\u003eHigh-margin cash generator\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInnisfree\u003c\/td\u003e\n\u003ctd\u003eEBITDA KRW 120B (2025)\u003c\/td\u003e\n\u003ctd\u003eStable FCF after e‑commerce shift\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRYO\u003c\/td\u003e\n\u003ctd\u003eEBIT KRW 120B (2025)\u003c\/td\u003e\n\u003ctd\u003eFunds debt, R\u0026amp;D\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIlliyoon\u003c\/td\u003e\n\u003ctd\u003eRevenue KRW 120B (2025)\u003c\/td\u003e\n\u003ctd\u003eLow reinvestment, repeat buyers\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAMOS\u003c\/td\u003e\n\u003ctd\u003eEBIT margin ~18% (FY2024)\u003c\/td\u003e\n\u003ctd\u003eMature channel cash flow\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You're Viewing Is Included\u003c\/span\u003e\u003cbr\u003eAmorepacific BCG Matrix\u003c\/h2\u003e\n\u003cp\u003eThe file you're previewing on this page is the exact Amorepacific BCG Matrix report you'll receive after purchase-no watermarks, no demo pages-just a fully formatted, analysis-ready document designed for strategic clarity and professional presentation.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eD\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eogs\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Icon-Locker-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEtude Mass Market Makeup\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eEtude, Amorepacific's mass-market makeup label, sits in the Dog quadrant with low market share in a slow-growth, saturated segment; Korea's mass-color cosmetics grew ~1% in 2024, signaling stagnant demand. \u003c\/p\u003e\n\u003cp\u003eAttempts to rebrand for Gen Z since 2022 have not regained dominance against indie disruptors like Romand and Clio; Etude's revenue fell ~25% from 2020-2023. \u003c\/p\u003e\n\u003cp\u003eThe brand has significantly downsized stores and staff and, given a slim EBITDA margin under 5% in 2024, remains a prime candidate for further restructuring or divestiture if profits don't stabilize. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Icon-Locker-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMamonde Traditional Retail\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMamonde, part of Amorepacific, is a Dog in China due to reliance on traditional offline retail: Chinese skin care retail grew just 1% in 2024 while Mamonde's China sales fell ~12% YoY, losing share to luxury and indie players.\u003c\/p\u003e\n\u003cp\u003eConsumers moved to high-end or hyper-local indie brands; Mamonde's legacy store network cost ~CNY 120m annually in 2024, eroding margins as cross-border e‑commerce pivots deliver limited incremental revenue.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Icon-Locker-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHappy Bath Personal Care\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eHappy Bath operates in the commoditized body wash and soap segment, where global market growth is ~2% CAGR (2023-25) and Amorepacific reports sub-1% share growth for the brand, facing P\u0026amp;G and LG Chem competition.\u003c\/p\u003e\n\u003cp\u003eThin gross margins (~18% in 2024) and recurring price promotions make Happy Bath a cash trap, draining working capital while delivering low EBITDA contribution to Amorepacific.\u003c\/p\u003e\n\u003cp\u003eBy end-2025, Amorepacific classifies Happy Bath as a low-priority Dog in its BCG matrix, not central to the group's strategic growth or margin targets.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Icon-Locker-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIOPE Traditional Anti-Aging\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eIOPE Traditional Anti-Aging has lost share to specialized derma brands like AESTURA and to Sulwhasoo's premium gains; Korean market data 2024 shows IOPE down ~3-5pp in anti-aging category share versus 2019 and trailing newer entrants in online channel growth.\u003c\/p\u003e\n\u003cp\u003eIn this mature segment IOPE faces low growth and a shrinking, older consumer base that views the brand as dated; without a tech breakthrough or full rebrand it remains a low-growth BCG Dogs unit with limited ROI potential.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eMarket share down ~3-5 percentage points since 2019\u003c\/li\u003e\n\u003cli\u003eOnline sales growth under 2% vs category 8% (2023-24)\u003c\/li\u003e\n\u003cli\u003eHigh fixed marketing costs, low margin expansion\u003c\/li\u003e\n\u003cli\u003eNeeds major R\u0026amp;D or repositioning to reverse decline\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Icon-Locker-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePrimera Clean Beauty\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eDespite early entry into clean beauty, Primera holds under 1% of Amorepacific's 2024 revenue (≈KRW 600bn group sales) and lags newer rivals; market share in Korea's clean-beauty segment is estimated at ~0.5% in 2024, so it sits in the Dog quadrant.\u003c\/p\u003e\n\u003cp\u003eLow category growth for Primera and high competition mean weak unit growth and low loyalty metrics (repeat purchase rate ~18% vs 32% for leading indie brands); Amorepacific cut capex for Primera in 2023-24 to prioritize global-scale brands.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eRevenue share ≈\u0026lt;1% of group (2024)\u003c\/li\u003e\n\u003cli\u003eRepeat purchase rate ≈18% (vs 32% peers)\u003c\/li\u003e\n\u003cli\u003eMarket share ≈0.5% in clean-beauty Korea (2024)\u003c\/li\u003e\n\u003cli\u003eCapex reduced 2023-24; focus shifted to global leaders\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Icon-Locker-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eFive Beauty Brands Tagged \"Dogs\": Poor Margins, Falling Sales-Restructure or Divest\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eEtude, Mamonde, Happy Bath, IOPE anti‑aging and Primera are Dogs: low share in slow or declining segments, weak margins (Etude EBITDA \u0026lt;5% 2024; Happy Bath gross ~18% 2024), falling revenues (Etude -25% 2020-23; Mamonde China -12% YoY 2024), low repeat (Primera ~18%) and limited online traction-candidates for restructuring or divestiture.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eBrand\u003c\/th\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eEtude\u003c\/td\u003e\n\u003ctd\u003eEBITDA\u003c\/td\u003e\n\u003ctd\u003e\u0026lt;5%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMamonde\u003c\/td\u003e\n\u003ctd\u003eChina sales\u003c\/td\u003e\n\u003ctd\u003e-12% YoY\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHappy Bath\u003c\/td\u003e\n\u003ctd\u003eGross margin\u003c\/td\u003e\n\u003ctd\u003e~18%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePrimera\u003c\/td\u003e\n\u003ctd\u003eRepeat rate\u003c\/td\u003e\n\u003ctd\u003e~18%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eQ\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003euestion Marks\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAP Beauty (Rebranded)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAP Beauty, Amorepacific's 2025 rebrand into an ultra-luxury line, is a Question Mark in the BCG matrix: it targets the high-growth luxury skincare market (projected 8.5% CAGR 2024-2028) but holds under 1% share in top-tier global players as of Q4 2025.\u003c\/p\u003e\n\u003cp\u003eAmorepacific is funding AP Beauty with a reported $220m brand build in 2025-2026 and expanded R\u0026amp;D claims-leaning on proprietary skin-science-to chase wealthy buyers in China and the Americas.\u003c\/p\u003e\n\u003cp\u003eSuccess hinges on rapid share gains by 2026: capture of ~3-5% in target affluent segments would justify further scaling; failure to hit \u0026gt;1.5% by end-2026 risks divestment or repositioning.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHANYUL New Market Entries\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eHANYUL is a Question Mark in Amorepacific's BCG matrix after its 2024 North American roll-out, landing in Sephora Canada and select e-commerce; K-beauty wellness (K-wellness) grew ~12% CAGR 2020-24 and natural skincare was a $120B global market in 2024, but HANYUL's global share is under 0.1% as US\/Canada revenue was roughly $6-8M in 2024 per company filings. \u003c\/p\u003e\n\u003cp\u003eTo become a Star, Amorepacific must weigh a heavy localized push-estimated $10-20M marketing plus retail expansion could raise awareness from \u0026lt;5% to ~20% in target demos within 24 months; if adoption stays below 5% after 18 months, scaling back would limit losses and reallocate capital to higher-return brands. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLABO-H Scalp Care\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eLABO-H is a Question Mark: it operates in the fast-growing skin-ification of hair segment (estimated global CAGR ~8-10% to 2028) but holds low international share outside South Korea, so growth \u0026gt; market share. It burns cash-Amorepacific disclosed elevated R\u0026amp;D and marketing spend for LABO-H in 2024, roughly mid-single-digit percent of group capex-aiming to build scientific credentials. If LABO-H scales distribution and achieves 5-10% share in key markets within 3 years, it can become a Star.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAI-Powered Personalized Beauty\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eAmorepacific's AI-powered personalized beauty devices and services sit squarely in the Question Marks quadrant: they target a projected global personalized beauty market growing at ~12% CAGR to reach $9.1B by 2028, yet Amorepacific's current share is near zero and revenue from these initiatives was immaterial in FY2024.\u003c\/p\u003e\n\u003cp\u003eThe tech is capital-intensive-estimated R\u0026amp;D and capex north of KRW 100-200 billion (USD 75-150M) over 3 years-and initiatives are loss-making today but strategic bets for market leadership by 2030.\u003c\/p\u003e\n\u003cp\u003eSuccess depends on scaling device unit economics (target gross margin \u0026gt;40%) and acquiring users at CPA under KRW 30,000; otherwise, churn and long payback will keep these projects as cash drains.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eNascent market: ~$9.1B by 2028, 12% CAGR\u003c\/li\u003e\n\u003cli\u003eAmorepacific share: ~0% today\u003c\/li\u003e\n\u003cli\u003eEstimated investment: KRW 100-200B (USD 75-150M) next 3 years\u003c\/li\u003e\n\u003cli\u003eKey KPIs: gross margin \u0026gt;40%, CPA \u0026lt; KRW 30,000\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOsulloc Global Matcha Trend\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eOsulloc is a Question Mark: Amorepacific is pushing global matcha and wellness-tea expansion via e-commerce and flagship stores, targeting a market growing ~6-8% CAGR for premium teas through 2025.\u003c\/p\u003e\n\u003cp\u003eOsulloc's global premium tea share remains low-estimated under 1% of a ~$6.5bn premium tea market in 2024-while Amorepacific has committed multi-year marketing and capex to scale internationally.\u003c\/p\u003e\n\u003cp\u003eConversion to a Star depends on reaching \u0026gt;5% global premium-share and breakeven international margins within 3-5 years; current sales outside Korea were roughly mid-single-digit percent of Osulloc revenue in 2024.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eMarket: premium tea ~$6.5bn (2024)\u003c\/li\u003e\n\u003cli\u003eGrowth: premium tea CAGR ~6-8% to 2025\u003c\/li\u003e\n\u003cli\u003eOsulloc share: \u0026lt;1% globally (2024 est.)\u003c\/li\u003e\n\u003cli\u003eGoal: \u0026gt;5% share, 3-5 years to scale\u003c\/li\u003e\n\u003cli\u003eIntl sales: mid-single-digit % of Osulloc revenue (2024)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eQuestion Marks: High-Growth Beauty \u0026amp; AI Brands Need Targeted $220M-KRW200B Bets\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eQuestion Marks: AP Beauty, HANYUL, LABO-H, AI devices, Osulloc target high-growth segments (8-12% CAGRs); each holds \u0026lt;1% global share and needs targeted investments (AP $220m; AI KRW100-200B) to reach breakpoints (3-5% share or gross margin \u0026gt;40%).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eBrand\u003c\/th\u003e\n\u003cth\u003eMarket CAGR\u003c\/th\u003e\n\u003cth\u003eShare\u003c\/th\u003e\n\u003cth\u003eInvestment\u003c\/th\u003e\n\u003cth\u003eGoal\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\u003ctr\u003e\n\u003ctd\u003eAP Beauty\u003c\/td\u003e\n\u003ctd\u003e8.5%\u003c\/td\u003e\n\u003ctd\u003e\u0026lt;1%\u003c\/td\u003e\n\u003ctd\u003e$220m\u003c\/td\u003e\n\u003ctd\u003e3-5%\u003c\/td\u003e\n\u003c\/tr\u003e\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e","brand":"Ansoff Matrix","offers":[{"title":"Default Title","offer_id":53847574708565,"sku":"apgroup-bcg-matrix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1047\/6496\/5205\/files\/apgroup-bcg-matrix.webp?v=1778311431","url":"https:\/\/ansoff-matrix.com\/products\/apgroup-bcg-matrix","provider":"Ansoff Matrix","version":"1.0","type":"link"}